Checkpoint inhibitor immunotherapy for glioblastoma: current progress, challenges and future outlook

INTRODUCTION: Despite maximal surgical resection and chemoradiation, glioblastoma (GBM) continues to be associated with significant morbidity and mortality. Novel therapeutic strategies are urgently needed. Given success in treating multiple other forms of cancer, checkpoint inhibitor immunotherapy...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Expert Rev Clin Pharmacol
Prif Awduron: Gedeon, Patrick C., Champion, Cosette D., Rhodin, Kristen E., Woroniecka, Karolina, Kemeny, Hanna R., Bramall, Alexa N., Bernstock, Joshua D., Choi, Bryan D., Sampson, John H.
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: 2020
Pynciau:
Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC7658017/
https://ncbi.nlm.nih.gov/pubmed/32862726
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/17512433.2020.1817737
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg